Product image of Lanoxin (Digoxin) supplied by GNH India

Lanoxin

Active Ingredient:
Digoxin
Origin:
EU

Lanoxin (Digoxin)

Digoxin, the active ingredient in Lanoxin, is a cardiac glycoside presented as an oral tablet for oral use. It treats heart failure and certain atrial arrhythmias in adult patients.
GNH India supplies Lanoxin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Aspen Pharma Trading Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lanoxin is a cardiac glycoside that acts on the heart muscle and the electrical conduction system.

  • Heart failure: improves cardiac output and reduces symptoms of fluid overload.
  • Atrial fibrillation: slows atrioventricular nodal conduction to control ventricular rate.
  • Atrial flutter: provides rate control by reducing AV‑node conduction.

How It Works

  • Digoxin binds to and inhibits the Na+/K+ ATPase pump on cardiac myocyte membranes, causing an increase in intracellular sodium. The elevated sodium reduces the activity of the Na+/Ca2+ exchanger, leading to higher intracellular calcium concentrations, which enhance myocardial contractility. Additionally, digoxin increases vagal tone, slowing conduction through the atrioventricular node and helping to control heart rate in atrial arrhythmias.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Vomiting: occasional emesis, especially after dose changes.
  • Diarrhea: loose stools may occur.
  • Fatigue: feeling of tiredness or weakness.
  • Blurred vision: visual disturbances such as halos.
  • Headache: mild headache reported.

Serious or Rare Side Effects

  • Arrhythmias: ventricular tachycardia or fibrillation.
  • Severe bradycardia: markedly slow heart rate.
  • Heart block: advanced AV block requiring pacing.
  • Hyperkalemia: elevated serum potassium levels.
  • Visual disturbances: yellow‑green halos or color vision changes.
  • Allergic reactions: rash, itching, or anaphylaxis.

Precautions & Warnings

When using Lanoxin, consider the following precautions:

  • Renal impairment: adjust dose and monitor serum digoxin levels.
  • Electrolyte disturbances: correct hypokalemia or hyperkalemia before therapy.
  • Concomitant AV block: avoid use without a functioning pacemaker.
  • Pregnancy: use only if benefits outweigh potential risks (Category C).
  • Elderly patients: start with lower doses and monitor closely.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Digoxin interacts with several medicines that can alter its plasma concentration or cardiac effects.

Major Interactions (Avoid)

  • Amiodarone: markedly increases digoxin levels.
  • Quinidine: raises digoxin concentrations.
  • Verapamil: enhances digoxin effect and risk of toxicity.
  • Diltiazem: may increase serum digoxin.
  • Erythromycin and other macrolide antibiotics: elevate digoxin levels.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: can cause hypokalemia, increasing toxicity risk.
  • ACE inhibitors: may potentiate digoxin's effects.
  • NSAIDs: may reduce renal clearance of digoxin.
  • Beta‑blockers: additive bradycardic effect.
  • Calcium channel blockers (non‑diltiazem): may require monitoring of heart rate.

Frequently Asked Questions

Lanoxin contains digoxin, which is used in the management of chronic heart failure and certain atrial arrhythmias such as atrial fibrillation and atrial flutter. It helps improve the strength of heart muscle contractions and provides rate control in these rhythm disorders.

Digoxin inhibits the Na+/K+ ATPase pump in cardiac cells, leading to increased intracellular sodium. This change reduces the activity of the Na+/Ca2+ exchanger, causing a rise in intracellular calcium that strengthens myocardial contraction. Additionally, digoxin enhances vagal tone, slowing conduction through the atrioventricular node and helping to control heart rate.

The dose of digoxin is individualized. A prescriber determines the appropriate strength and schedule based on factors such as the patient’s age, renal function, body weight, and clinical response. Dose adjustments are common, especially in patients with renal impairment or when interacting medications are present.

Digoxin is classified as pregnancy category C, meaning risk cannot be ruled out. It should be used only if the potential benefit justifies the potential risk to the fetus. Limited data exist for breastfeeding; caution is advised and a healthcare professional should evaluate the risk‑benefit ratio before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Digoxin offers a unique mechanism by directly increasing cardiac contractility and providing rate control, unlike ACE inhibitors, beta‑blockers, or diuretics that act on neuro‑hormonal pathways. Contemporary guidelines often reserve digoxin for patients who remain symptomatic despite optimal standard therapy, making it a complementary option rather than a first‑line agent.

Store Lanoxin at ambient temperature below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Do not refrigerate or freeze the tablets, and keep the container tightly closed to maintain product stability.

Lanoxin is taken orally as a tablet, with or without food as directed by the prescriber. The tablet should be swallowed whole with a glass of water; crushing or chewing is not recommended unless specifically instructed by a healthcare professional.

The most critical risks include cardiac arrhythmias such as ventricular tachycardia, severe bradycardia, or heart block, especially when serum digoxin levels become elevated. Other serious concerns are hyperkalemia, visual disturbances like yellow‑green halos, and allergic reactions. Immediate medical attention is required if any of these occur.

Lanoxin is contraindicated in individuals with known hypersensitivity to digoxin, uncontrolled ventricular arrhythmias, high‑grade AV block without a functioning pacemaker, and severe electrolyte disturbances, particularly hyperkalemia. Caution is also advised in patients with significant renal impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.